Compounds > edotreotide
Page last updated: 2024-09-04

edotreotide and bismuth

edotreotide has been researched along with bismuth in 3 studies

Compound Research Comparison

Studies
(edotreotide)		Trials
(edotreotide)		Recent Studies (post-2010)
(edotreotide)		Studies
(bismuth)		Trials
(bismuth)		Recent Studies (post-2010) (bismuth)
20634866,6626712,138

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (33.33)29.6817
2010's2 (66.67)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Anderson, T; Atcher, R; Nayak, T; Norenberg, J1
Apostolidis, C; Boll, R; Bruchertseifer, F; Giesel, FL; Haberkorn, U; Kratochwil, C; Mier, W; Morgenstern, A; Murphy, K1

Other Studies

3 other study(ies) available for edotreotide and bismuth

ArticleYear
A comparison of high- versus low-linear energy transfer somatostatin receptor targeted radionuclide therapy in vitro.
    Cancer biotherapy & radiopharmaceuticals, 2005, Volume: 20, Issue:1

    Topics: Actinium; Alpha Particles; Apoptosis; Beta Particles; Bismuth; Cell Line, Tumor; Cell Nucleus; Cell Survival; Dose-Response Relationship, Radiation; Energy Transfer; Enzyme-Linked Immunosorbent Assay; Humans; Ligands; Lutetium; Mitosis; Models, Statistical; Neoplasms; Octreotide; Radioisotopes; Radiometry; Radiopharmaceuticals; Receptors, Somatostatin

2005
SNM 2012 image of the year.
    Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2012, Volume: 53, Issue:10

    Topics: Bismuth; Humans; Intestinal Neoplasms; Liver; Neuroendocrine Tumors; Nuclear Medicine; Octreotide; Pancreatic Neoplasms; Radioisotopes; Radionuclide Imaging; Societies, Scientific; Stomach Neoplasms; Treatment Failure

2012
²¹³Bi-DOTATOC receptor-targeted alpha-radionuclide therapy induces remission in neuroendocrine tumours refractory to beta radiation: a first-in-human experience.
    European journal of nuclear medicine and molecular imaging, 2014, Volume: 41, Issue:11

    Topics: Adult; Alpha Particles; Beta Particles; Bismuth; Female; Humans; Male; Molecular Targeted Therapy; Neoplasm Metastasis; Neuroendocrine Tumors; Octreotide; Positron-Emission Tomography; Radioisotopes; Receptors, Somatostatin; Retrospective Studies; Tomography, X-Ray Computed; Treatment Failure

2014